Multivitamins and infections
This article was originally published in The Tan Sheet
"Evidence for routine use of multivitamin and mineral supplements to reduce infections in elderly people is weak and conflicting," Alia El-Kadiki, University of Leicester, England, et al., report in the April 16 British Medical Journal. The authors conducted a meta-analysis of eight studies collected from Medline and other databases that evaluated the effect of multivitamins on infections in the elderly. The assessment focused on the mean difference in number of days spent with infection, the odds rate of at least one infection in the study period and the incidence rate ratio for the difference in infection rates. Three of the eight studies showed multivitamin use reduced the mean annual number of days spent with infection by 17.5, the authors note...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”